CANCER THERAPY - Cancer patients in the UK are receiving a new therapeutic to help their bodies recognise and fight cancer cells as part of a global trial.
The UK launches groundbreaking Mobilize trial using mRNA-4359 for melanoma and lung cancer, tapping into the patient's immune system for targeted and less toxic cancer treatment.